₹ 938.43 Cr
2.29%
S&P BSE Healthcare TRI
INF789F01695
5000.0
1000.0
500
Kamal Gada
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
UTI Healthcare Fund - Regular Plan - Growth Option | 51.37 | 13.06 | 24.81 |
S&P BSE Healthcare TRI | 50.08 | 13.58 | 22.23 |
Equity
Debt
Others
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.82 |
Cipla Ltd. | 6.79 |
Ajanta Pharma Ltd. | 5.95 |
Dr. Reddy's Laboratories Ltd. | 4.83 |
Apollo Hospitals Enterprise Ltd. | 4.23 |
Aurobindo Pharma Ltd. | 3.79 |
Eris Lifesciences Ltd. | 3.38 |
Gland Pharma Ltd. | 3.33 |
Torrent Pharmaceuticals Ltd. | 3.3 |
Procter & Gamble Health Ltd. | 3.28 |
Sector | Holdings (%) |
---|---|
Healthcare | 97.31 |
Insurance | 1.59 |
Others | 0.97 |
Financial | 0.13 |
Scheme Name | 5Y (%) |
---|---|
UTI Healthcare Reg Gr | 24.81 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 27.6 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 25.17 |
Nippon India Pharma Fund Gr Gr | 26.37 |
Mirae Asset Healthcare Reg Gr | 27.12 |
LIC MF Healthcare Fund Reg Gr | 20.85 |
SBI HEALTHCARE Opportunities Reg Gr | 26.98 |
DSP Healthcare Reg Gr | 27.95 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |